Concepts (293)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetes Mellitus, Type 2 | 10 | 2025 | 677 | 2.920 |
Why?
|
| Obesity | 15 | 2018 | 811 | 2.690 |
Why?
|
| African Americans | 11 | 2019 | 394 | 1.820 |
Why?
|
| Social Determinants of Health | 2 | 2024 | 39 | 1.570 |
Why?
|
| Weight Loss | 13 | 2022 | 302 | 1.520 |
Why?
|
| Dietary Approaches To Stop Hypertension | 3 | 2026 | 8 | 1.410 |
Why?
|
| Humans | 58 | 2026 | 16832 | 1.380 |
Why?
|
| Diabetes Mellitus | 6 | 2023 | 445 | 1.300 |
Why?
|
| Blood Pressure | 4 | 2026 | 278 | 1.280 |
Why?
|
| Self Care | 6 | 2017 | 139 | 1.250 |
Why?
|
| Hypertension | 5 | 2026 | 475 | 1.220 |
Why?
|
| Weight Reduction Programs | 4 | 2018 | 51 | 1.210 |
Why?
|
| Overweight | 4 | 2019 | 262 | 1.110 |
Why?
|
| Behavior Therapy | 5 | 2018 | 121 | 1.100 |
Why?
|
| Delivery of Health Care, Integrated | 3 | 2022 | 515 | 1.060 |
Why?
|
| Patient Education as Topic | 4 | 2017 | 186 | 1.040 |
Why?
|
| Female | 36 | 2026 | 12193 | 0.970 |
Why?
|
| Self-Management | 2 | 2025 | 25 | 0.930 |
Why?
|
| Health Behavior | 7 | 2022 | 332 | 0.890 |
Why?
|
| Life Style | 4 | 2018 | 305 | 0.870 |
Why?
|
| Male | 30 | 2026 | 9556 | 0.860 |
Why?
|
| Adult | 24 | 2026 | 7255 | 0.850 |
Why?
|
| Racism | 1 | 2024 | 23 | 0.810 |
Why?
|
| Prenatal Care | 1 | 2025 | 123 | 0.790 |
Why?
|
| Primary Health Care | 3 | 2017 | 693 | 0.740 |
Why?
|
| Health Equity | 1 | 2023 | 26 | 0.730 |
Why?
|
| Pregnancy Complications | 1 | 2025 | 202 | 0.730 |
Why?
|
| Prediabetic State | 2 | 2021 | 63 | 0.690 |
Why?
|
| Middle Aged | 20 | 2026 | 7515 | 0.680 |
Why?
|
| Blood Glucose | 1 | 2023 | 315 | 0.660 |
Why?
|
| Referral and Consultation | 2 | 2017 | 147 | 0.580 |
Why?
|
| Decision Making | 3 | 2016 | 164 | 0.550 |
Why?
|
| Feeding Behavior | 3 | 2014 | 161 | 0.540 |
Why?
|
| Glycated Hemoglobin A | 5 | 2022 | 176 | 0.540 |
Why?
|
| Centers for Medicare and Medicaid Services (U.S.) | 1 | 2017 | 4 | 0.520 |
Why?
|
| Behavioral Medicine | 1 | 2017 | 4 | 0.520 |
Why?
|
| Aged | 11 | 2026 | 5901 | 0.510 |
Why?
|
| Obesity Management | 1 | 2017 | 4 | 0.510 |
Why?
|
| Metabolic Syndrome | 2 | 2018 | 59 | 0.500 |
Why?
|
| Societies, Medical | 1 | 2017 | 67 | 0.500 |
Why?
|
| Surveys and Questionnaires | 8 | 2025 | 1204 | 0.490 |
Why?
|
| Social Isolation | 2 | 2025 | 20 | 0.490 |
Why?
|
| Physicians | 1 | 2017 | 114 | 0.480 |
Why?
|
| Psychometrics | 3 | 2014 | 114 | 0.470 |
Why?
|
| Research Design | 2 | 2021 | 319 | 0.460 |
Why?
|
| Exercise | 6 | 2025 | 513 | 0.450 |
Why?
|
| Autonomic Nervous System | 1 | 2015 | 3 | 0.450 |
Why?
|
| Asthma | 3 | 2011 | 375 | 0.440 |
Why?
|
| Heart Rate | 1 | 2015 | 33 | 0.440 |
Why?
|
| Emigrants and Immigrants | 1 | 2015 | 26 | 0.430 |
Why?
|
| Problem Solving | 1 | 2014 | 7 | 0.430 |
Why?
|
| Diet, Sodium-Restricted | 2 | 2026 | 23 | 0.430 |
Why?
|
| Lost to Follow-Up | 1 | 2014 | 2 | 0.410 |
Why?
|
| Boston | 4 | 2026 | 31 | 0.400 |
Why?
|
| Stress, Psychological | 1 | 2015 | 136 | 0.400 |
Why?
|
| Electronic Health Records | 2 | 2019 | 702 | 0.390 |
Why?
|
| Body Mass Index | 9 | 2026 | 925 | 0.380 |
Why?
|
| Models, Statistical | 1 | 2013 | 164 | 0.370 |
Why?
|
| Psychosomatic Medicine | 1 | 2012 | 1 | 0.360 |
Why?
|
| Chronic Disease | 1 | 2014 | 382 | 0.360 |
Why?
|
| Models, Psychological | 1 | 2012 | 21 | 0.350 |
Why?
|
| Immunoglobulin E | 1 | 2011 | 5 | 0.350 |
Why?
|
| Medicare | 3 | 2025 | 188 | 0.330 |
Why?
|
| Treatment Outcome | 9 | 2026 | 1098 | 0.320 |
Why?
|
| Telemedicine | 2 | 2025 | 190 | 0.300 |
Why?
|
| Cholesterol, LDL | 2 | 2026 | 113 | 0.280 |
Why?
|
| Young Adult | 5 | 2024 | 2456 | 0.260 |
Why?
|
| Gastric Bypass | 2 | 2022 | 71 | 0.260 |
Why?
|
| European Continental Ancestry Group | 5 | 2019 | 400 | 0.260 |
Why?
|
| Fruit | 3 | 2023 | 79 | 0.260 |
Why?
|
| United States | 6 | 2025 | 3858 | 0.250 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2025 | 317 | 0.250 |
Why?
|
| Obesity, Morbid | 2 | 2022 | 122 | 0.250 |
Why?
|
| Annexin A2 | 3 | 2001 | 3 | 0.240 |
Why?
|
| Follow-Up Studies | 3 | 2017 | 1058 | 0.230 |
Why?
|
| Fibrinolysin | 4 | 2001 | 4 | 0.220 |
Why?
|
| Minority Groups | 2 | 2023 | 99 | 0.220 |
Why?
|
| Adolescent | 8 | 2022 | 3464 | 0.220 |
Why?
|
| Budesonide | 2 | 2001 | 2 | 0.220 |
Why?
|
| Needs Assessment | 1 | 2025 | 64 | 0.220 |
Why?
|
| Spatial Analysis | 1 | 2024 | 11 | 0.210 |
Why?
|
| Pragmatic Clinical Trials as Topic | 1 | 2025 | 63 | 0.210 |
Why?
|
| Pre-Eclampsia | 1 | 2025 | 41 | 0.210 |
Why?
|
| Community Networks | 1 | 2024 | 19 | 0.210 |
Why?
|
| Vegetables | 2 | 2019 | 88 | 0.210 |
Why?
|
| Body Weight | 4 | 2018 | 197 | 0.210 |
Why?
|
| Emotions | 1 | 2024 | 32 | 0.210 |
Why?
|
| Health Promotion | 2 | 2023 | 277 | 0.210 |
Why?
|
| Gender Identity | 1 | 2024 | 33 | 0.200 |
Why?
|
| Precision Medicine | 1 | 2023 | 28 | 0.190 |
Why?
|
| Health Status | 2 | 2023 | 256 | 0.190 |
Why?
|
| Program Evaluation | 2 | 2016 | 211 | 0.190 |
Why?
|
| Cocaine | 1 | 2023 | 6 | 0.190 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2023 | 70 | 0.180 |
Why?
|
| Bronchodilator Agents | 1 | 2001 | 21 | 0.180 |
Why?
|
| Pilot Projects | 1 | 2022 | 210 | 0.170 |
Why?
|
| Residence Characteristics | 1 | 2023 | 244 | 0.170 |
Why?
|
| Fibroma | 1 | 2021 | 1 | 0.170 |
Why?
|
| Gingival Neoplasms | 1 | 2021 | 2 | 0.170 |
Why?
|
| Cannabis | 1 | 2023 | 79 | 0.170 |
Why?
|
| Bariatric Surgery | 1 | 2022 | 134 | 0.160 |
Why?
|
| Quality of Life | 2 | 2014 | 477 | 0.150 |
Why?
|
| Counseling | 2 | 2026 | 170 | 0.150 |
Why?
|
| Opioid-Related Disorders | 1 | 2023 | 174 | 0.150 |
Why?
|
| Pregnancy | 1 | 2025 | 1555 | 0.150 |
Why?
|
| Risk Factors | 3 | 2016 | 3108 | 0.150 |
Why?
|
| Evidence-Based Medicine | 2 | 2023 | 160 | 0.150 |
Why?
|
| Phentermine | 1 | 2019 | 11 | 0.150 |
Why?
|
| Mental Health Services | 1 | 2021 | 132 | 0.150 |
Why?
|
| Appetite Depressants | 1 | 2019 | 16 | 0.150 |
Why?
|
| Substance-Related Disorders | 1 | 2023 | 305 | 0.150 |
Why?
|
| Stair Climbing | 1 | 2019 | 1 | 0.150 |
Why?
|
| Social Support | 2 | 2018 | 195 | 0.140 |
Why?
|
| Urban Population | 2 | 2016 | 105 | 0.140 |
Why?
|
| Healthy Aging | 1 | 2019 | 11 | 0.140 |
Why?
|
| Diet Therapy | 1 | 2018 | 9 | 0.140 |
Why?
|
| Choice Behavior | 2 | 2016 | 44 | 0.140 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2025 | 352 | 0.140 |
Why?
|
| Self Report | 2 | 2023 | 248 | 0.140 |
Why?
|
| Health Status Disparities | 1 | 2019 | 145 | 0.130 |
Why?
|
| Women's Health | 1 | 2019 | 178 | 0.130 |
Why?
|
| Exercise Therapy | 1 | 2018 | 71 | 0.130 |
Why?
|
| Mentoring | 1 | 2017 | 29 | 0.120 |
Why?
|
| Interviews as Topic | 1 | 2017 | 305 | 0.120 |
Why?
|
| Socioeconomic Factors | 3 | 2014 | 571 | 0.120 |
Why?
|
| Ethnic Groups | 1 | 2019 | 418 | 0.120 |
Why?
|
| Insurance Coverage | 1 | 2017 | 102 | 0.120 |
Why?
|
| Plasminogen | 3 | 2001 | 3 | 0.120 |
Why?
|
| Cohort Studies | 5 | 2022 | 2396 | 0.120 |
Why?
|
| Health Personnel | 1 | 2017 | 132 | 0.120 |
Why?
|
| Child | 5 | 2014 | 2433 | 0.120 |
Why?
|
| Severity of Illness Index | 2 | 2011 | 410 | 0.110 |
Why?
|
| Qualitative Research | 1 | 2017 | 288 | 0.110 |
Why?
|
| Practice Guidelines as Topic | 1 | 2017 | 311 | 0.110 |
Why?
|
| Respiratory Rate | 1 | 2015 | 1 | 0.110 |
Why?
|
| Goals | 1 | 2015 | 27 | 0.110 |
Why?
|
| Emigration and Immigration | 1 | 2015 | 14 | 0.110 |
Why?
|
| Tissue and Organ Procurement | 1 | 2014 | 3 | 0.110 |
Why?
|
| Patient Compliance | 2 | 2014 | 262 | 0.110 |
Why?
|
| Tissue Donors | 1 | 2014 | 7 | 0.110 |
Why?
|
| Patient Care Team | 1 | 2015 | 98 | 0.110 |
Why?
|
| Neuropsychological Tests | 1 | 2014 | 47 | 0.110 |
Why?
|
| Video Recording | 1 | 2014 | 18 | 0.110 |
Why?
|
| Kidney Transplantation | 1 | 2014 | 28 | 0.100 |
Why?
|
| Reproducibility of Results | 2 | 2013 | 346 | 0.100 |
Why?
|
| Bulimia | 1 | 2014 | 8 | 0.100 |
Why?
|
| Energy Metabolism | 1 | 2013 | 47 | 0.100 |
Why?
|
| Community-Based Participatory Research | 1 | 2014 | 45 | 0.100 |
Why?
|
| Nebulizers and Vaporizers | 2 | 2011 | 9 | 0.100 |
Why?
|
| Diet | 1 | 2015 | 349 | 0.100 |
Why?
|
| African Continental Ancestry Group | 1 | 2013 | 117 | 0.100 |
Why?
|
| Kidney Failure, Chronic | 1 | 2014 | 144 | 0.100 |
Why?
|
| Binge-Eating Disorder | 1 | 2013 | 13 | 0.090 |
Why?
|
| Pediatric Obesity | 1 | 2014 | 101 | 0.090 |
Why?
|
| Nutrition Surveys | 1 | 2012 | 56 | 0.090 |
Why?
|
| Culture | 2 | 2009 | 28 | 0.090 |
Why?
|
| Patient Participation | 1 | 2013 | 120 | 0.090 |
Why?
|
| Multivariate Analysis | 1 | 2014 | 489 | 0.090 |
Why?
|
| Motor Activity | 1 | 2014 | 196 | 0.090 |
Why?
|
| Proportional Hazards Models | 1 | 2014 | 657 | 0.090 |
Why?
|
| Neutrophils | 1 | 2011 | 2 | 0.090 |
Why?
|
| New York City | 1 | 2011 | 22 | 0.090 |
Why?
|
| Peak Expiratory Flow Rate | 1 | 2011 | 13 | 0.090 |
Why?
|
| Leukocyte Count | 1 | 2011 | 23 | 0.090 |
Why?
|
| Data Interpretation, Statistical | 1 | 2012 | 67 | 0.090 |
Why?
|
| Family Characteristics | 2 | 2014 | 69 | 0.090 |
Why?
|
| Patient Selection | 1 | 2013 | 175 | 0.090 |
Why?
|
| Cardiovascular Diseases | 1 | 2016 | 520 | 0.090 |
Why?
|
| Forced Expiratory Volume | 1 | 2011 | 59 | 0.090 |
Why?
|
| Cities | 1 | 2011 | 28 | 0.090 |
Why?
|
| Administration, Oral | 1 | 2011 | 81 | 0.090 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2011 | 66 | 0.080 |
Why?
|
| Sensitivity and Specificity | 1 | 2012 | 291 | 0.080 |
Why?
|
| Anti-Asthmatic Agents | 1 | 2011 | 85 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2001 | 110 | 0.080 |
Why?
|
| Disease Progression | 1 | 2011 | 252 | 0.080 |
Why?
|
| Nutritive Value | 1 | 2009 | 11 | 0.080 |
Why?
|
| Perception | 1 | 2009 | 53 | 0.080 |
Why?
|
| Tissue Plasminogen Activator | 2 | 2000 | 24 | 0.070 |
Why?
|
| Veterans | 1 | 2010 | 143 | 0.070 |
Why?
|
| Hispanic Americans | 1 | 2011 | 350 | 0.070 |
Why?
|
| Aged, 80 and over | 2 | 2025 | 1887 | 0.070 |
Why?
|
| Animals | 4 | 2001 | 237 | 0.060 |
Why?
|
| Chicago | 2 | 2019 | 24 | 0.060 |
Why?
|
| Urban Health | 1 | 2006 | 35 | 0.060 |
Why?
|
| Food Preferences | 1 | 2006 | 23 | 0.060 |
Why?
|
| Costs and Cost Analysis | 1 | 2006 | 58 | 0.060 |
Why?
|
| Retrospective Studies | 3 | 2022 | 2463 | 0.060 |
Why?
|
| Nutritionists | 1 | 2026 | 1 | 0.060 |
Why?
|
| Blood Pressure Determination | 1 | 2026 | 57 | 0.060 |
Why?
|
| Administration, Inhalation | 2 | 2001 | 39 | 0.050 |
Why?
|
| Double-Blind Method | 2 | 2001 | 138 | 0.050 |
Why?
|
| Consensus | 1 | 2023 | 40 | 0.050 |
Why?
|
| Social Justice | 1 | 2023 | 8 | 0.050 |
Why?
|
| Cattle | 2 | 2001 | 10 | 0.050 |
Why?
|
| Prevalence | 2 | 2019 | 785 | 0.050 |
Why?
|
| Enzyme Activation | 2 | 2000 | 8 | 0.050 |
Why?
|
| Hypnotics and Sedatives | 1 | 2023 | 10 | 0.050 |
Why?
|
| Substance Abuse Detection | 1 | 2023 | 16 | 0.050 |
Why?
|
| Cell Membrane | 2 | 2000 | 5 | 0.050 |
Why?
|
| Gastrectomy | 1 | 2022 | 47 | 0.050 |
Why?
|
| Recurrence | 1 | 2022 | 149 | 0.050 |
Why?
|
| Internet | 2 | 2014 | 207 | 0.040 |
Why?
|
| Infant Welfare | 1 | 2001 | 4 | 0.040 |
Why?
|
| Time | 1 | 2001 | 16 | 0.040 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2001 | 5 | 0.040 |
Why?
|
| Peptide Fragments | 1 | 2001 | 29 | 0.040 |
Why?
|
| Withholding Treatment | 1 | 2001 | 26 | 0.040 |
Why?
|
| Depression | 2 | 2018 | 479 | 0.040 |
Why?
|
| Cost-Benefit Analysis | 1 | 2022 | 229 | 0.040 |
Why?
|
| Emergency Service, Hospital | 1 | 2025 | 393 | 0.040 |
Why?
|
| Child Welfare | 1 | 2001 | 39 | 0.040 |
Why?
|
| Fibrin | 1 | 2001 | 1 | 0.040 |
Why?
|
| Fibrinolysis | 1 | 2001 | 2 | 0.040 |
Why?
|
| Infant | 2 | 2001 | 1212 | 0.040 |
Why?
|
| Masks | 1 | 2000 | 4 | 0.040 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2000 | 27 | 0.040 |
Why?
|
| Hydrolysis | 1 | 2000 | 1 | 0.040 |
Why?
|
| Substrate Specificity | 1 | 2000 | 1 | 0.040 |
Why?
|
| Cell Line | 1 | 2000 | 9 | 0.040 |
Why?
|
| Enzyme Inhibitors | 1 | 2000 | 4 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2000 | 29 | 0.040 |
Why?
|
| Analgesics, Opioid | 1 | 2023 | 239 | 0.040 |
Why?
|
| Kidney | 1 | 2000 | 51 | 0.040 |
Why?
|
| Hospitalization | 1 | 2025 | 816 | 0.040 |
Why?
|
| Michigan | 1 | 2019 | 26 | 0.040 |
Why?
|
| Receptors, Cell Surface | 1 | 1998 | 6 | 0.040 |
Why?
|
| Osteoarthritis | 1 | 2019 | 15 | 0.040 |
Why?
|
| Time Factors | 1 | 2001 | 989 | 0.040 |
Why?
|
| Alabama | 2 | 2009 | 22 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2001 | 1430 | 0.030 |
Why?
|
| Depressive Disorder | 1 | 2018 | 177 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 653 | 0.030 |
Why?
|
| Kidney Tubules, Proximal | 1 | 1996 | 1 | 0.030 |
Why?
|
| Oxidants | 1 | 1996 | 2 | 0.030 |
Why?
|
| Lipid Peroxidation | 1 | 1996 | 4 | 0.030 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 1996 | 5 | 0.030 |
Why?
|
| Hydrogen Peroxide | 1 | 1996 | 2 | 0.030 |
Why?
|
| Television | 1 | 2014 | 14 | 0.030 |
Why?
|
| Adolescent Health Services | 1 | 2014 | 36 | 0.030 |
Why?
|
| Sleep | 1 | 2014 | 54 | 0.030 |
Why?
|
| Health Education | 1 | 2014 | 79 | 0.030 |
Why?
|
| Child Health Services | 1 | 2014 | 104 | 0.020 |
Why?
|
| Personality Inventory | 1 | 2013 | 11 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 2013 | 25 | 0.020 |
Why?
|
| Sleep Wake Disorders | 1 | 2013 | 31 | 0.020 |
Why?
|
| Patient-Centered Care | 1 | 2014 | 185 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2013 | 325 | 0.020 |
Why?
|
| Comorbidity | 1 | 2013 | 516 | 0.020 |
Why?
|
| Nutritional Status | 1 | 2010 | 32 | 0.020 |
Why?
|
| Program Development | 1 | 2010 | 62 | 0.020 |
Why?
|
| Cooking | 1 | 2009 | 17 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 1 | 2009 | 27 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 2 | 2001 | 16 | 0.020 |
Why?
|
| Mice | 2 | 2001 | 59 | 0.020 |
Why?
|
| Sex Factors | 1 | 2011 | 560 | 0.020 |
Why?
|
| Age Factors | 1 | 2011 | 814 | 0.020 |
Why?
|
| Cells, Cultured | 2 | 1998 | 12 | 0.020 |
Why?
|
| School Health Services | 1 | 2006 | 39 | 0.020 |
Why?
|
| Focus Groups | 1 | 2007 | 140 | 0.020 |
Why?
|
| Allantois | 1 | 2001 | 1 | 0.010 |
Why?
|
| Circular Dichroism | 1 | 2001 | 1 | 0.010 |
Why?
|
| Kringles | 1 | 2001 | 1 | 0.010 |
Why?
|
| Carcinoma, Lewis Lung | 1 | 2001 | 1 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 2001 | 6 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2001 | 3 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2001 | 5 | 0.010 |
Why?
|
| Chick Embryo | 1 | 2001 | 2 | 0.010 |
Why?
|
| Mass Spectrometry | 1 | 2001 | 6 | 0.010 |
Why?
|
| Neovascularization, Pathologic | 1 | 2001 | 3 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2001 | 10 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2001 | 16 | 0.010 |
Why?
|
| Endothelium, Vascular | 1 | 2001 | 4 | 0.010 |
Why?
|
| Protein Conformation | 1 | 2001 | 2 | 0.010 |
Why?
|
| Kinetics | 1 | 2001 | 12 | 0.010 |
Why?
|
| Glycerol | 1 | 2001 | 5 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2001 | 41 | 0.010 |
Why?
|
| Lung | 1 | 2001 | 52 | 0.010 |
Why?
|
| Suspensions | 1 | 2000 | 1 | 0.010 |
Why?
|
| Administration, Topical | 1 | 2000 | 5 | 0.010 |
Why?
|
| Glucocorticoids | 1 | 2000 | 22 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2000 | 94 | 0.010 |
Why?
|
| alpha-2-Antiplasmin | 1 | 1998 | 1 | 0.010 |
Why?
|
| Aminocaproic Acid | 1 | 1998 | 1 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 1998 | 1 | 0.010 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 1998 | 2 | 0.010 |
Why?
|
| Lysine | 1 | 1998 | 2 | 0.010 |
Why?
|
| Mutagenesis | 1 | 1998 | 4 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 1998 | 16 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2001 | 268 | 0.010 |
Why?
|
| Epithelium | 1 | 1996 | 2 | 0.010 |
Why?
|
| Cell Division | 1 | 1996 | 4 | 0.010 |
Why?
|
| Malondialdehyde | 1 | 1996 | 2 | 0.010 |
Why?
|
Concepts
(293)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(19)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_
-->